Genome Editing in Mouse Spermatogonial Stem/Progenitor Cells Using Engineered Nucleases
Author(s) -
Danielle A. Fanslow,
Stacey E. Wirt,
Jenny C. Barker,
Jon P. Connelly,
Matthew H. Porteus,
Christina Tenenhaus Dann
Publication year - 2014
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0112652
Subject(s) - homologous recombination , biology , genome editing , germline , stem cell , microbiology and biotechnology , progenitor cell , genome engineering , gene , transplantation , genetics , genome , computational biology , medicine , surgery
Editing the genome to create specific sequence modifications is a powerful way to study gene function and promises future applicability to gene therapy. Creation of precise modifications requires homologous recombination, a very rare event in most cell types that can be stimulated by introducing a double strand break near the target sequence. One method to create a double strand break in a particular sequence is with a custom designed nuclease. We used engineered nucleases to stimulate homologous recombination to correct a mutant gene in mouse “GS” (germline stem) cells, testicular derived cell cultures containing spermatogonial stem cells and progenitor cells. We demonstrated that gene-corrected cells maintained several properties of spermatogonial stem/progenitor cells including the ability to colonize following testicular transplantation. This proof of concept for genome editing in GS cells impacts both cell therapy and basic research given the potential for GS cells to be propagated in vitro , contribute to the germline in vivo following testicular transplantation or become reprogrammed to pluripotency in vitro .
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom